Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200
Closed -$65.5K 1794
2025
Q4
$65.5K Buy
+200
New +$63.4K 0.01% 1478
2025
Q3
Sell
-409
Closed -$114K 1828
2025
Q2
$114K Sell
409
-273
-40% -$77.3K 0.01% 1238
2025
Q1
$212K Buy
+682
New +$201K 0.03% 760
2023
Q4
Sell
-260
Closed -$69.9K 1603
2023
Q3
$69.9K Buy
+260
New +$64.9K 0.02% 1091
2023
Q2
Sell
-995
Closed -$241K 1554
2023
Q1
$241K Sell
995
-16
-2% -$3.93K 0.08% 234
2022
Q4
$266K Buy
1,011
+291
+40% +$78K 0.09% 188
2022
Q3
$162K Buy
+720
New +$175K 0.08% 307
2022
Q2
Sell
-409
Closed -$99K 1853
2022
Q1
$99K Sell
409
-263
-39% -$60.4K 0.05% 593
2021
Q4
$151K Buy
672
+70
+12% +$14.8K 0.07% 355
2021
Q3
$128K Buy
+602
New +$139K 0.08% 325

Other funds holding AMGN

State of Wyoming's AMGN Position: Q1 2026 in Review

State of Wyoming sold out of Amgen (AMGN) in Q1 2026, closing a stake of 200 shares — an estimated $65.5K sold.

State of Wyoming first reported a position in AMGN in Q3 2021 and held it in 10 quarters. The position peaked at $266K in Q4 2022. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • State of Wyoming reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • State of Wyoming sold 200 Amgen shares in Q1 2026, an estimated $65.5K.
  • State of Wyoming first reported a position in Amgen in Q3 2021 and held it in 10 quarters.
  • State of Wyoming's Amgen position peaked at $266K in Q4 2022.
  • 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.